These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 8019192)

  • 1. New treatments for dementia. Myth, magic, and science.
    Ganesan R; Standish T; Molloy DW; Darzins P; Orange JB
    Can Fam Physician; 1994 Jun; 40():1149-57. PubMed ID: 8019192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Canadian study of health and aging: study methods and prevalence of dementia.
    CMAJ; 1994 Mar; 150(6):899-913. PubMed ID: 8131123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pharmacological effects of ginkgo biloba, a plant extract, on the brain of dementia patients in comparison with tacrine.
    Itil TM; Eralp E; Ahmed I; Kunitz A; Itil KZ
    Psychopharmacol Bull; 1998; 34(3):391-7. PubMed ID: 9803773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Geriatric ethics: dementia and the quality of life.
    Ainslie N; Bartholome W; Ruhl C
    Kans Med; 1994 Jul; 95(7):174-5. PubMed ID: 7933774
    [No Abstract]   [Full Text] [Related]  

  • 5. Dying with dementia: the views of family caregivers about quality of life.
    Russell C; Middleton H; Shanley C
    Australas J Ageing; 2008 Jun; 27(2):89-92. PubMed ID: 18713199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Ethical and legal issues in late stage of dementia].
    Fernandes L
    Acta Med Port; 2008; 21(1):65-71. PubMed ID: 18489837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tacrine granted marketing approval for Alzheimer's disease.
    Clin Pharm; 1993 Dec; 12(12):873, 876. PubMed ID: 8137602
    [No Abstract]   [Full Text] [Related]  

  • 8. Attitudes of physicians, nurses and relatives towards end-of-life decisions concerning nursing home patients with dementia.
    Rurup ML; Onwuteaka-Philipsen BD; Pasman HR; Ribbe MW; van der Wal G
    Patient Educ Couns; 2006 Jun; 61(3):372-80. PubMed ID: 15975757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Developing treatment guidelines for Alzheimer's disease and other dementias.
    Rabins PV
    J Clin Psychiatry; 1996; 57 Suppl 14():37-8. PubMed ID: 9024335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving the quality of care for mild to moderate dementia: an evaluation of the Croydon Memory Service Model.
    Banerjee S; Willis R; Matthews D; Contell F; Chan J; Murray J
    Int J Geriatr Psychiatry; 2007 Aug; 22(8):782-8. PubMed ID: 17243196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The attitudes of carers and old age psychiatrists towards the treatment of potentially fatal events in end-stage dementia.
    Coetzee RH; Leask SJ; Jones RG
    Int J Geriatr Psychiatry; 2003 Feb; 18(2):169-73. PubMed ID: 12571827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Piracetam, nimodipine and tacrine in the pharmacologic treatment of dementia: bibliographic review].
    Ojer Tsakiridu D; Dosantos Hernández JO; Larrabe Medina J; Sánchez Casado JI; Sologuren Echenagusia A
    Aten Primaria; 1996 Sep; 18(5):257-60, 262-4. PubMed ID: 8936720
    [No Abstract]   [Full Text] [Related]  

  • 13. Recommendations for best practices in the treatment of Alzheimer's disease in managed care.
    Fillit HM; Doody RS; Binaso K; Crooks GM; Ferris SH; Farlow MR; Leifer B; Mills C; Minkoff N; Orland B; Reichman WE; Salloway S
    Am J Geriatr Pharmacother; 2006; 4 Suppl A():S9-S24; quiz S25-S28. PubMed ID: 17157793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Goals of care in advanced dementia: quality of life, dignity and comfort.
    Volicer L
    J Nutr Health Aging; 2007; 11(6):481. PubMed ID: 17985063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benzodiazepine utilization patterns in Alzheimer's disease patients.
    Lagnaoui R; Moore N; Moride Y; Miremont-Salamé G; Bégaud B
    Pharmacoepidemiol Drug Saf; 2003 Sep; 12(6):511-5. PubMed ID: 14513664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health utilities in mild cognitive impairment and dementia: a population study in Sweden.
    Ekman M; Berg J; Wimo A; Jönsson L; McBurney C
    Int J Geriatr Psychiatry; 2007 Jul; 22(7):649-55. PubMed ID: 17136704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Where we stand with treating dementia.
    Amador L; Jayaraj K
    N C Med J; 2000; 61(4):209-14. PubMed ID: 10917038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maximizing function in Alzheimer's disease: what role for tacrine?
    Smucker WD
    Am Fam Physician; 1996 Aug; 54(2):645-52. PubMed ID: 8701842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defining and measuring outcomes in end-stage dementia.
    Teno JM; Landrum K; Lynn J
    Alzheimer Dis Assoc Disord; 1997; 11 Suppl 6():25-9. PubMed ID: 9437445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New therapeutic approaches to cognitive impairment.
    Schneider LS
    J Clin Psychiatry; 1998; 59 Suppl 11():8-13. PubMed ID: 9731544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.